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A biphasic developmental cycle whereby highly resistant small-cell variants (SCVs) are generated from
large-cell variants (LCVs) is considered fundamental to the virulence of Coxiella burnetii, the causative agent
of human Q fever. In this study a proteome analysis of C. burnetii developmental forms was conducted to
provide insight into their unique biological and immunological properties. Silver-stained gels of SCV and LCV
lysates separated by two-dimensional (2-D) gel electrophoresis resolved over 675 proteins in both develop-
mental forms. Forty-eight proteins were greater than twofold more abundant in LCVs than in SCVs, with six
proteins greater than twofold more abundant in SCVs than in LCVs. Four and 15 upregulated proteins of SCVs
and LCVs, respectively, were identified by mass spectrometry, and their predicted functional roles are con-
sistent with a metabolically active LCV and a structurally resistant SCV. One-dimensional and 2-D immuno-
blots of cell form lysates probed with sera from infected/vaccinated guinea pigs and convalescent-phase serum
from human patients who had recovered from acute Q fever, respectively, revealed both unique SCV/LCV
antigens and common SCV/LCV antigens that were often differentially synthesized. Antigens recognized during
human infection were identified by mass spectroscopy and included both previously described immunodomi-
nant proteins of C. burnetii and novel immunogenic proteins that may be important in the pathophysiology of
clinical Q fever and/or the induction of protective immunity.
Coxiella burnetii is the etiologic agent of an acute, disabling
influenza-like illness in humans termed Q fever. In rare in-
stances chronic disease can occur, usually presenting as hepa-
titis or endocarditis. C. burnetii infects a wide range of verte-
brate and invertebrate hosts and is found worldwide with the
exception of New Zealand. Most human Q fever cases are
acquired through inhalation of contaminated aerosols orig-
inating from products shed from chronically infected domes-
tic livestock. Indeed, massive numbers of coxiellae (109/g)
are present in the products of parturition (reviewed in ref-
erence 19).
C. burnetii has an obligate requirement for replication in a
eukaryotic host cell vacuole with lysosomal characteristics (15).
Resistance to this harsh intracellular environment correlates
with remarkable environmental stability, a trait that distin-
guishes C. burnetii from other obligate intracellular bacteria.
The pathogen is highly resistant to osmotic shock, elevated
temperature, desiccation, UV light, and various chemical dis-
infectants (21, 36). Environmental stability, along with aerosol
transmission and an infectious dose approaching one organ-
ism, has resulted in classification of C. burnetii as a CDC
category B biothreat. The spore-like characteristics of C. bur-
netii are attributed to a stable small-cell variant (SCV) that
arises as part of a C. burnetii biphasic developmental cycle (22).
SCVs are rod shaped and 0.2 to 0.5 m in length and have an
electron-dense condensed chromatin with an array of intracy-
toplasmic membranes. Large-cell variants (LCVs) can exceed 1
m in length and are pleomorphic with a dispersed chromatin
(12, 22). C. burnetii preparations enriched in LCVs are more
metabolically active in vitro than those enriched in SCVs (21).
By infecting Vero cells with SCVs, we have recently estab-
lished the kinetics of C. burnetii morphological development
and defined the LCV as the replicative form of the pathogen
(5). The C. burnetii growth cycle has defined lag, log, and
stationary phases (5). SCV-to-LCV morphogenesis occurs dur-
ing a lag phase lasting approximately 2 days. Exponential rep-
lication of LCVs ensues over the next 4 days with LCVs con-
densing to SCVs in significant numbers during a stationary
phase that starts approximately 6 days postinfection (p.i.).
Elucidation of the molecular events that regulate C. burnetii
development has been hampered by an inability to genetically
manipulate the organism; however, some progress has been
made in identifying developmental-form-specific proteins. Mc-
Caul et al. (20) identified a 29.5-kDa immunogenic protein
termed P1 that is differentially synthesized by the LCV. The
encoding gene was later cloned by Varghees et al. (33), who
described P1 as having porin activity. Additional proteins that
are dramatically enriched in the LCV include EF-Tu and
EF-Ts (26) and RpoS (28). Two DNA-binding proteins, ScvA
and Hq1, are preferentially expressed by the SCV (13, 14).
Intracellular morphological differentiation to generate envi-
ronmentally stable SCV and replicatively active LCV develop-
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mental forms is considered central to Coxiella virulence. How-
ever, the unique or upregulated proteins that confer the
distinctive ultrastructural and biological characteristics of
SCVs and LCVs are still largely unknown, as are the immu-
nogenic constituents of developmental forms that are recog-
nized during infection. The recent elucidation of the genome
sequence of the Nine Mile isolate (RSA493) of C. burnetii (27)
now allows a proteomic approach, i.e., two-dimensional (2-D)
gel electrophoresis combined with peptide mass mapping and
fingerprinting to address these problems. Using these ap-
proaches, we conducted an analysis of C. burnetii SCV and
LCV protein composition and the developmental form anti-
gens recognized during infection.
MATERIALS AND METHODS
Cultivation and purification of C. burnetii. C. burnetii Nine Mile Crazy
(RSA514) was grown in African green monkey kidney (Vero) fibroblasts (CCL-
81; American Type Culture Collection) cultivated in RPMI (Invitrogen) supple-
mented with 10% fetal bovine serum. This strain was isolated from the placenta
of a guinea pig that had been chronically infected for 343 days with the reference
Nine Mile phase I strain (RSA439) (9). Bacteria were purified from infected cells
at 7 days p.i. by Renografin gradient centrifugation (37). SCVs and LCVs were
separated by equilibrium density centrifugation in 32% cesium chloride (CsCl2)
as previously described (14). Cell variants were resuspended in K-36 (0.1 M KCl,
0.015 M NaCl, 0.05 M potassium phosphate, pH 7.0) and stored at 80°C.
Immune sera. A guinea pig was aerosol infected with 106 C. burnetii Nine Mile
bacteria in phase I (RSA493) and bled for immune sera at 7, 14, and 28 days p.i.
Guinea pig immune serum was also generated by vaccination and subsequent
challenge with live organisms. Specifically, a guinea pig was vaccinated with 40 g
of formalin-fixed Nine Mile phase I bacteria mixed 1:1 in incomplete Freund’s
adjuvant and boosted 14 days later. After 2 weeks vaccinated animals were
aerosol challenged with 106 live Nine Mile phase I bacteria, and immune serum
was harvested at 28 days p.i. (Protocols for production of guinea pig immune sera
were approved by the Texas A&M University Institutional Animal Care and Use
Committee.) Human convalescent-phase sera from two patients who had recov-
ered from acute Q fever were obtained from an Australian serum collection
recently acquired by J.E.S. Generation of anti-ScvA serum has been previously
described (14).
One-dimensional gel electrophoresis and immunoblotting. Proteins of CsCl2-
purified SCVs and LCVs were separated by polyacrylamide gel electrophoresis
as previously described (14) using NextGel polyacrylamide solution (Amresco,
Solon, OH). For both one-dimensional and 2-D gels (below), equal amounts of
SCV and LCV protein were separated as determined by the RC DC protein
assay (Bio-Rad). Gels were stained with a SilverQuest silver staining Kit (In-
vitrogen). Proteinase K digestion of C. burnetii proteins was conducted by first
solubilizing organisms in lysis buffer (2% sodium dodecyl sulfate, 4% 2-mercapto-
ethanol, 10% glycerol, 1 M Tris [pH 8.8], and 0.2% bromophenol blue) at 100°C
for 5 min. Samples were then cooled and treated with 20 g of recombinant
proteinase K (Roche Applied Science) for 4 h at 60°C while being mixed at 700
rpm in a Thermomixer (Brinkmann Instruments, Inc.). For immunoblotting,
proteins were electrophoretically transferred to Immobilon P (Millipore) and
blocked in phosphate-buffered saline (10 mM sodium phosphate, 150 mM so-
dium chloride, pH 7.4) plus 5% nonfat dry milk and 0.1% Tween 20. Guinea pig
immune sera and human convalescent-phase sera were used at a 1:500 dilution,
and rabbit anti-ScvA was used at a 1:4,000 dilution. Peroxidase-conjugated anti-
guinea pig (Sigma), anti-human, or anti-rabbit (ICN) immunoglobulin G sec-
ondary antibodies were used at a 1:50,000 dilution. Bound antibodies were
detected by chemiluminescence using Supersignal West Pico chemiluminescent
substrate (Pierce) and Hyperfilm ECL (Amersham).
2-D electrophoresis. Purified SCVs and LCVs were solubilized and processed
using the Bio-Rad ReadyPrep system. Proteins were focused using pH 4 to 7, pH
7 to 10, or pH 3 to 10 nonlinear ReadyStrips (Bio-Rad). Focused proteins were
separated by polyacrylamide gel electrophoresis and stained with silver as de-
scribed above. Wet gels were scanned using a Hewlett-Packard ScanJet 5300C,
and digitized images were analyzed using ImageJ (written by W. S. Rasband at
the U.S. National Institutes of Health, Bethesda, MD, and available from http:
//rsb.info.nih.gov/ij/) and Phoretix 2-D Evolution (v2005) software (Nonlinear
Dynamics, Newcastle-upon-Tyne, United Kingdom). Scanned images were con-
verted to grayscale and inverted, and the integrated pixel density of identical
areas of corresponding SCV and LCV spots was calculated. (The background
staining of individual gels, as determined by averaging the minimum intensity
from three different gel areas, was subtracted from each calculation.) Proteins
were considered uniquely or differentially expressed between developmental
forms if a greater-than-twofold difference in pixel density was observed.
Mass spectrometry. Gel slices were destained, buffer equilibrated, dehydrated,
and then rehydrated with 25 l of porcine trypsin (Promega) at 20 g/ml in 25
mM ammonium bicarbonate (pH 8.0). After an overnight incubation at 37°C,
peptides were extracted and dried, and lysines were converted to homoarginine
by adding 10 l of 1 M O-methylisourea sulfate (pH 11) (Sigma) and incubating
the mixture at 37°C for 2 h. Five microliters of 5% trifluoroacetic acid was added
to the modified peptides, and they were subsequently purified using C18 Zip-Tips
(Millipore). Purified peptides were dried and then rehydrated with 1.5 l of
matrix solution consisting of 2.5 mg/ml -cyano-4-hydroxycinnamic acid (Sigma)
in a solution of 40% acetonitrile, 0.1% trifluoroacetic acid. An 0.5-l volume of
the peptide-matrix solution was spotted on the sample plate and allowed to air
dry. Matrix-assisted laser desorption ionization–time of flight (TOF) mass spec-
tra and peptide mass fingerprints were collected by using an Applied Biosystems/
MDS Sciex 4800 matrix-assisted laser desorption ionization TOF/TOF mass
spectrometry workstation (Applied Biosystems, Framington, MA). The resulting
peptide peak list and peptide fragment list were submitted for a search of the
CDS combined database (Celera Discovery System) by using the Mascot (Matrix
Science) search software.
Transmission electron microscopy. Purified SCVs and LCVs were fixed over-
night at 4°C with 2.5% glutaraldehyde-4% paraformaldehyde in 100 mM sodium
cacodylate buffer (pH 7.2). Cells were postfixed with 0.5% osmium tetroxide-
0.8% potassium ferricyanide in 100 mM sodium cacodylate buffer followed by
1% tannic acid in distilled water. Samples were stained overnight with 1% uranyl
acetate, washed with distilled water, dehydrated with a graded ethanol series, and
embedded in Spurr’s resin. Thin sections were stained with 1% uranyl acetate
and Reynold’s lead citrate. Sections were viewed at 80 kV on a Philips CM-10
transmission electron microscope (FEI, Hillsboro, OR). Digital images were
acquired with an AMT digital camera (AMT, Chazy, NY) and processed with
Adobe Photoshop (version 7.0; Adobe Systems, Mountain View, CA).
RESULTS
Purification of SCVs and LCVs. Earlier electrophoresis
studies revealed distinct protein heterogeneity between SCVs
and LCVs (12, 14, 20). To more completely assess the degree
of differential protein synthesis by SCVs and LCVs, we con-
ducted a proteomic analysis using 2-D electrophoresis and
silver staining. Highly pure preparations of sample are re-
quired for reproducible proteome surveys. In a previous study,
we fractionated SCVs and LCVs of the Nine Mile phase I
strain by exploiting their different buoyant densities in CsCl2
equilibrium gradients (35). While nearly homogeneous popu-
lations of developmental forms were obtained, yields were low
due to the poor infectivity of phase I C. burnetii for tissue
culture cells, a characteristic partly attributed to its hydro-
philic, full-length lipopolysaccharide (LPS) (23, 37). The Nine
Mile phase II variant is approximately 500 times more infec-
tious for cultured cells (23); however, a severely truncated LPS
makes this isolate highly hydrophobic, which causes it to ag-
gregate in CsCl2 (12). We therefore investigated whether the
Nine Mile Crazy variant, which produces an intermediate-
length LPS and is roughly 20 times more infectious for cell
culture than the Nine Mile phase I strain (23), could be sep-
arated by CsCl2 equilibrium density centrifugation. Clear sep-
aration of Nine Mile Crazy was achieved with LCVs banding at
a higher density than SCVs due to their presumed permeability
to CsCl2 (35) (Fig. 1A). Although C. burnetii was harvested at
7 days p.i., when the intracellular numbers of SCVs and LCVs
are roughly equal (5), the yield of purified SCVs always greatly
exceeded that of LCVs, a result attributed to the fragile nature
of the LCV. Ultrastructural analysis by transmission electron
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microscopy showed that nearly homogeneous SCVs and LCVs
were isolated using this procedure (Fig. 1B). Prototypic SCVs
were observed that were 0.2 to 0.5 m in length and rod
shaped and with an electron-dense condensed chromatin (Fig.
1B, left panel). The LCV ultrastructure was also typical with
cell forms approximately 1 m in length, pleomorphic, and
displaying a granular appearance due to a dispersed chromatin
(Fig. 1B, right panel). The homogeneity of SCV and LCV
fractions was further confirmed by immunoblotting for ScvA,
an SCV-specific protein (5, 14, 28) (Fig. 1C). ScvA was de-
tected only in lysates of fractionated SCV.
Comparison of SCV and LCV proteomes. Lysates of purified
cell forms were separated in the first dimension using immo-
bilized pH gradient strips having a pH range of 4 to 7 or 7 to
10. This protocol was employed to better resolve the C. burnetii
proteome and to facilitate detection of low-abundance pro-
teins. In both pH ranges combined, over 675 protein spots were
detected in 2-D gels of both SCV and LCV lysates (Fig. 2).
Based on densitometry, 48 proteins were greater than two-
fold more abundant in LCVs than in SCVs, with 32 and 16 of
these proteins having isoelectric points between pH 4 and 7
and pH 7 and 10, respectively. Fifteen upregulated LCV pro-
teins were identified by mass spectrometry, two of which were
proteins of unknown function (Table 1). In general, identified
proteins had predicted functions in general bacterial physiol-
ogy including transcription (N utilization protein A [NusA]),
translation (ribosomal protein S1 [RpsA], ribosomal protein
L9 [RplI], and elongation factor EF-Tu), cell division (cell
division protein FtsZ), chromosome partitioning (segregation
and condensation protein B [ScpB] and chromosome partition-
ing protein ParB), riboflavin biosynthesis (6,7,-dimethyl-8-ribi-
tyllumazine synthase [RibH]), and protein folding (60-kDa
FIG. 1. Purification and characterization of the C. burnetii SCV and LCV. (A) The SCV and LCV of the C. burnetii Nine Mile Crazy variant
were separated by equilibrium density centrifugation in 32% cesium chloride (CsCl2). LCVs (lower band) are denser than SCVs due to their
permeability to CsCl2 (12). (B) Transmission electron micrographs of fractionated SCVs (left panel) and LCVs (right panel) showing the
characteristic size and ultrastructure of developmental forms. Bars, 2.0 m. (C) Confirmation of SCV and LCV fractionation by immunoblotting
for ScvA. Shown are a silver-stained polyacrylamide gel of separated SCV (S) and LCV (L) lysates (left panel) and a parallel immunoblot (right
panel) probed with polyclonal antiserum to ScvA, an SCV-specific protein (14). Molecular mass markers at the left are expressed in kDa.
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chaperone [GroEL] and chaperone protein HtpG), and their
upregulation is consistent with the LCV being more metabol-
ically and replicatively active than the SCV (5, 21). Upregula-
tion of stringent starvation protein (SspA) (10), universal stress
protein A (UspA) (24), and thioredoxin peroxidase (Bcp) (38)
may reflect a stress response to the lysosomal environment by
the LCV.
Six proteins were detected that were greater than twofold
more abundant in SCVs than in LCVs, all having isoelectric
points between 7 and 10 (Fig. 2). Four of these were iden-
tified by mass spectrometry as TolB, a protein involved in
outer membrane stability (17); GTP binding protein Era
homolog (Era) (3); cystathionine beta-lyase (MetC); and a
hypothetical protein (Table 1). C. burnetii genes encode an
unusually high number of basic proteins with 24% having
a predicted isoelectric point greater than 10 (27). Obvious
FIG. 2. Silver-stained 2-D gel profiles of SCV and LCV proteins. Equal amounts of SCV and LCV lysates were subjected to 2-D gel
electrophoresis using pH 4 to 7 and pH 7 to 10 isoelectric focusing strips. Black circles denote proteins that are greater than twofold more abundant
in LCVs than in SCVs as determined by scanning densitometry. (Black circles are placed at the same coordinates on SCV 2-D gels to facilitate
protein level comparisons.) White circles denote proteins that are greater than twofold more abundant in SCVs than in LCVs as determined by
scanning densitometry. (White circles are placed at the same coordinates on LCV 2-D gels to facilitate protein level comparisons.) Numbered
circles denote proteins that were identified by mass spectrometry (Table 1). Molecular mass markers at left are expressed in kDa.
TABLE 1. Identification of differentially expressed SCV and LCV proteins
No. SCV/LCVa Gene Description Predicted mass (kDa) Predicted pI
1 LCV CBU0528 Ribosomal protein S1 (RpsA) 62.1 5.0
2 LCV CBU0867 Ribosomal protein L9 (RplI) 16.6 6.6
3 LCV CBU1433 N utilization substance protein A (NusA) 56.2 4.3
4 LCV CBU0236 Elongation factor EF-Tu 43.5 5.2
5 LCV CBU1718 60-kDa chaperone (GroEL) 58.3 4.9
6 LCV CBU0309 Chaperone protein HtpG (HtpG) 72.8 5.0
7 LCV CBU1747 Stringent starvation protein A (SspA) 24.4 5.6
8 LCV CBU0141 Cell division protein FtsZ (FtsZ) 40.7 4.3
9 LCV CBU1060 Segregation and condensation protein (ScpB) 23.7 4.4
10 LCV CBU0658 Hypothetical protein 16.0 4.5
11 LCV CBU1754 Hypothetical protein 22.3 4.7
12 LCV CBU1927 Chromosome partitioning protein ParB (ParB) 32.0 9.4
13 LCV CBU0963 Thioredoxin peroxidase (Bcp) 16.9 8.0
14 LCV CBU0648 DMRLb synthase (RibH) 16.6 7.3
15 LCV CBU1916 Universal stress protein A (UspA) 15.9 7.2
16 SCV CBU0090 TolB protein (TolB) 47.8 8.9
17 SCV CBU2025 Cystathionine beta-lyase (MetC) 42.7 8.3
18 SCV CBU2079 Hypothetical 14.2 8.6
19 SCV CBU1502 GTP binding protein Era homolog (Era) 33.9 9.4
a Unique to or upregulated greater than twofold in the LCV or the SCV.
b DMRL, 6,7,-dimethyl-8-ribityllumazine.
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stacking of unresolved high-isoelectric-point proteins was
observed at the basic end of pH 7 to 10 2-D gels, particularly
with SCV lysates (Fig. 2).
Immunodominant SCV and LCV antigens recognized by
guinea pigs. Differentially expressed components of SCVs and
LCVs might include immunogenic determinants that play im-
portant roles in the adaptive immune response to C. burnetii
infection. To date, just one developmentally regulated antigen
has been identified: P1, a porin protein preferentially ex-
pressed by LCVs (33). To determine the extent of differential
antigen synthesis by SCVs and LCVs, immunoblots of devel-
opmental form lysates were probed with sera from infected
and vaccinated/challenged guinea pigs and with sera from hu-
man patients who had recovered from acute Q fever.
An increasingly complex array of antigens was recognized by
serum derived from a single infected guinea pig at 7, 14, and 28
days p.i. (Fig. 3A). Two predominant low-molecular-mass an-
tigens of 12.5 and 15 kDa were recognized throughout the
course of infection in both SCV and LCV lysates. LPS of the
Nine Mile Crazy variant migrates on a polyacrylamide gel with
a molecular mass of 12 to 14 kDa (2). To determine if serum
reactivity to LPS was associated with either low-molecular-
mass antigen, lysates were digested with proteinase K before
immunoblotting. A proteinase-resistant antigen of 12.5 kDa
was detected in SCV and LCV lysates with 28-day-p.i. serum,
but not 7- or 14-day-p.i. serum (Fig. 3b), that comigrated with
purified C. burnetii Crazy LPS (data not shown). Fourteen-day-
postinfection serum recognized an additional 150-kDa antigen
in SCVs. Serum obtained at 28 days p.i. recognized 12.5-, 15-,
24-, 30-, 55-, 75-, 92-, and 94-kDa antigens in both SCV and
LCV fractions. This serum also uniquely recognized two LCV
antigens with approximate molecular masses of 42 and 84 kDa.
(The four bands comprising the 75- to 94-kDa LCV reactivity
are evident with shorter exposures.) Guinea pig immune serum
generated by vaccination with formalin-fixed C. burnetii and
subsequent challenge with viable organisms recognized fewer
antigens in both SCVs and LCVs than did 28-day-p.i. serum.
Serum reactivity was observed with the 12.5-, 15-, 30-, and
92-kDa common LCV/SCV antigens, and the 84-kDa LCV-
specific antigen, that was recognized with 28-day-p.i. serum.
Also detected was a novel 22-kDa antigen specific to the SCV.
No SCV or LCV antigens were recognized by sera from naı¨ve
guinea pigs (data not shown). Collectively, these results indi-
cate that SCVs and LCVs express unique antigens. Moreover,
based on immunoblot signal intensities, some shared antigens
are associated with developmental forms in different amounts.
SCV and LCV antigens recognized by convalescent-phase
sera from patients who recovered from acute Q fever. Conva-
lescent-phase immune sera from two patients who had recov-
ered from acute Q fever (2036 and 3004) were analyzed for
immunoreactivity against SCV and LCV antigens separated by
2-D gel electrophoresis (Fig. 4). Serum 2036 recognized 20
SCV and 26 LCV antigens. Fifteen antigens were common to
both cell variants, five were unique to SCV, and 11 were
unique to LCV. By overlaying films of immunoblots with par-
allel silver-stained gels, we identified by mass spectrometry 10
strongly immunogenic antigens that were generally shared by
SCVs and LCVs. Identified common cell variant antigens rec-
ognized by patient serum 2036 were GroEL, ribosomal protein
L7/L12 (RplJ), acute disease antigen A (AdaA), trigger factor
(Tig), and 3-oxoacyl-acyl carrier protein synthase II (FabF)
(Table 2). Identified LCV-specific antigens included Bcp and
repressor protein C2. Serum 3004 recognized 24 SCV and 27
LCV antigens. Thirteen antigens were common to both devel-
opmental forms with 11 and 14 antigens unique to SCV and
LCV, respectively. Identified antigens common to both cell
variants included GroEL, elongation factor EF-Tu, RplJ, ATP
synthase F-1 alpha subunit (AtpA), FabF, and isocitrate dehy-
drogenase (Icd) (Table 2). Tig was recognized only in LCV
lysates. We were unable to identify SCV-specific antigens rec-
ognized by either serum.
DISCUSSION
We have previously demonstrated by gel electrophoresis a
few differences in protein composition between C. burnetii
SCV and LCV developmental forms (12, 14); however, at-
tempts to extensively identify developmental form-specific pro-
teins were not undertaken due to low yields of purified cell
variants coupled with the lack of sensitive methods for protein
identification. Moreover, previous studies were hampered by
poor solubilization of cell variants, with fewer than 200 SCV
and LCV proteins resolved by 2-D gel electrophoresis and
silver staining (12). In this study we exploited improved yields
and solubilization of C. burnetii developmental forms along
with a dual-pH-range 2-D electrophoresis procedure to de-
velop a more complete proteome map of the SCV and the
LCV by more than tripling the number of proteins resolved by
silver staining over a previous study (12). Forty-eight proteins
FIG. 3. Temporal analysis of antibody development against SCV
and LCV antigens. (A) Immunoblots containing an equal amount of
SCV (S) and LCV (L) lysates were probed with sera derived from a C.
burnetii-infected guinea pig at 7, 14, and 28 days p.i. or with serum
derived from a guinea pig vaccinated with formalin-fixed C. burnetii
and then challenged with live organisms (V/C) (see Materials and
Methods). (B) Immunoblot of proteinase K-digested lysates probed
with infected guinea pig sera. Depicted is the region of the immunoblot
showing a digestion-resistant product that comigrates with Nine Mile
Crazy LPS. Film exposures for all immunoblots were conducted for
30 s. Molecular mass markers at left are expressed in kDa.
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are greater than twofold more abundant in LCVs than in
SCVs, with six proteins greater than twofold more abundant in
SCVs than in LCVs. Thus, the morphological differences ob-
served between C. burnetii developmental forms clearly corre-
late with differences in protein composition.
Using mass spectroscopy, we identified 15 of the 48 proteins
differentially synthesized by the LCV. These proteins are gen-
erally involved in cell division, RNA synthesis, and protein
synthesis/processing. As the more metabolically active cell
form of C. burnetii (5, 21), the LCV would be expected to have
increased ribosome content. Consistent with this idea, we iden-
tified upregulation by the LCV of N utilization substance pro-
tein A (NusA), a protein required for robust transcription of
rRNA (34), and the ribosomal proteins S1 and L9. Further
FIG. 4. Two-dimensional immunoblots of SCV and LCV lysates showing antigens recognized by convalescent-phase sera from two human
patients who had recovered from Q fever. Isoelectric focusing of proteins was conducted using pH 3 to 10 nonlinear (NL) strips. Immunoreactive
spots were cross-referenced with parallel silver-stained gels. Stained proteins that clearly correlated with immunoreactive spots were processed for
mass spectrometry. Identified antigens are denoted with circles and numbers. Spots on other gels that have coordinates identical to those of mass
spectrometry-identified antigens are denoted with circles and asterisked numbers. Identified antigens are listed in Table 2. (Some immunoreactive
protein spots are difficult to visualize in the figure but are clearly visible in the original films.) Molecular mass markers at left are expressed in kDa.
TABLE 2. Identification of immunoreactive SCV and LCV proteins
No. Gene Description Predicted mass(kDa)
Predicted
pI
Serum 2036 Serum 3004
Cell variant
MS/MS
identificationa
Spot in other
cell variant
lysateb
Cell variant
MS/MS
identificationa
Spot in other
cell variant
lysateb
1 CBU1718 60-kDa chaperone (GroEL) 58.3 4.9 S  SL NAc
2 CBU0236 Elongation factor EF-Tu 43.5 5.2 NA SL NA
3 CBU0229 Ribosomal protein L7/L12 (RplJ) 13.2 4.4 S  SL NA
4 CBU1943 ATP synthase F-1 alpha subunit (AtpA) 58.8 6.0 NA L 
5 CBU1416 Repressor protein C2 24.3 7.6 L NA
6 CBU0952 Acute disease antigen A (AdaA) 26.0 9.3 L  NA
7 CBU0963 Thioredoxin peroxidase (Bcp) 16.9 8.0 L NA
8 CBU0737 Trigger factor (Tig) 50.2 5.1 d L
9 CBU0497 3-Oxoacyl-acyl carrier protein synthase II
(FabF)
44.1 5.5 d L 
10 CBU1200 Isocitrate dehydrogenase (Icd) 46.6 6.4 NA L 
a Protein identified by mass spectrometry in lysates of the SCV (S), the LCV (L), or both (SL).
b Corresponding spot present in immunoblot of lysates derived from other cell variants is indicated with a .
c NA, not applicable.
d Immunoreactive spot at the same coordinates in both SCV and LCV 2-D immunoblots as those of the protein identified by serum 3004 in the LCV.
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enhancing the translational machinery of the LCV is upregu-
lation of EF-Tu, a finding in keeping with a previous study
(26). We have recently confirmed that the LCV is the replica-
tively active cell form of the C. burnetii developmental cycle
(5). As such, and in accordance with increased metabolic ac-
tivity, the LCV upregulates FtsZ, required for bacterial binary
fission, and two proteins involved in chromosome partitioning,
ScpB and ParB (11, 30), relative to the SCV.
At first glance, upregulation of stringent starvation protein
A (SspA) by the LCV seems counterintuitive as, among other
effects, expression of this protein in Escherichia coli results in
increased synthesis of the stationary-phase sigma factor RpoS
(10). However, we (5) and others (28) have previously shown
that RpoS is upregulated by the LCV during exponential
growth, where it potentially induces genes involved in protect-
ing C. burnetii against lysosomal stress. Indeed, RpoS induction
of hydroperoxidase I in exponentially growing Vibrio vulnificus
is critical for survival of this organism during oxidative stress
(25). In addition to regulating RpoS levels, SspA is thought to
be a global regulator of bacterial virulence genes (10). Along
with SspA, elevated levels of Bcp, UspA, GroEL, and HtpG in
the LCV also support the idea that this developmental form is
responding to lysosomal stress. As a thioredoxin peroxidase,
Bcp resides within the general family of thiol-specific antioxi-
dant proteins termed peroxiredoxins. They are abundant pro-
teins in bacteria and serve to detoxify various peroxide com-
pounds (38). In E. coli, UspA is essential for survival of a
variety of insults including exposure to hydrogen peroxide (24).
While the chaperones GroEL and HtpG are abundant in bac-
teria growing under normal conditions, they are also upregu-
lated in response to a variety of adverse conditions (6, 29).
Moreover, GroEL and HtpG are implicated in protein secre-
tion (16, 32), and we have previously speculated that the LCV
is the secretion-competent form of C. burnetii (5).
The most abundant LCV-upregulated protein that we iden-
tified is annotated as a hypothetical protein (CBU0658). The
Coxiella genome encodes a high proportion of hypothetical
proteins (33.7% of coding sequences) (27). It is reasonable to
suspect that these play critical roles in C. burnetii morpholog-
ical development and pathogenesis; however, their functional
assignments await future biochemical and genetic analysis. We
did not exhaustively attempt to identify by mass spectrometry
the remaining subset of LCV-upregulated proteins. However,
it likely includes RpoS and EF-Ts, previously described as
differentially synthesized by the LCV (35, 37), as LCV-upregu-
lated proteins with molecular masses and pIs approximating
those of these proteins are present on 2-D gels.
We identified four proteins differentially synthesized by the
SCV with three, TolB, Era homolog, and MetC, having pre-
dicted functions. In E. coli, TolB interacts with other Tol pro-
teins to stabilize the outer membrane (17). Elevated TolB
levels in the SCV may partially explain this developmental
form’s noted resistance to physical disruption. The E. coli pro-
tein Era is a member of the small regulatory GTPase super-
family (3). Among the proposed functions of Era and its
homologs are regulation of the cell cycle and cellular differen-
tiation (3). For example, Era homologs of Bacillus subtilis are
required for normal cell division and spore formation (1, 4).
Thus, this protein may be a key regulator of SCV morpholog-
ical differentiation. Upregulation of MetC, a biosynthetic en-
zyme, by the SCV is puzzling. This enzyme catalyzes the last
intermediate of the methionine biosynthetic pathway, convert-
ing cystathionine to L-homocysteine. In E. coli, homocysteine
globally affects transcription and inhibits growth by perturbing
the activity of threonine deaminase, which results in depletion
of branched-chain amino acids (8, 31). Consequently, homo-
cysteine may serve a similar signaling role in the SCV to down-
regulate metabolism. Alternatively, SCV may require more
methionine for production of S-adenosylmethionine. Among
the many uses of S-adenosylmethionine is production of
spermine and spermidine (7). These cationic polyamines bind
to DNA which stabilizes the molecule and facilitates chromatin
condensation (1), a hallmark of the SCV. Two very basic SCV-
specific DNA-binding proteins, ScvA and Hq1, have been pre-
viously described (13, 14) that also presumably play roles in
chromatin condensation. Interestingly, all SCV-upregulated
proteins were found in pH 7 to 10 2-D gels. Moreover, there is
an abundance of unresolved SCV proteins that “stack up” at
the basic end of pH 7 to 10 2-D gels relative to the LCV. In
addition to ScvA and Hq1, these likely include additional SCV-
upregulated proteins involved in chromatin condensation or
other processes that contribute to the resistance properties of
SCV. Resolution and identification of these proteins will re-
quire an alternative method of protein fractionation. Similarly
to the LCV, the most abundant SCV-upregulated protein
based on densitometry is annotated as a hypothetical protein
(CBU2079).
P1 is the only surface antigen known to be differentially
synthesized by C. burnetii developmental forms (20, 33). Here
we extensively examined SCV and LCV antigens recognized in
the context of both infection and vaccination with killed or-
ganisms. An infected guinea pig developed antibodies to an
increasingly complex array of SCV and LCV antigens over the
time course of infection. Although different levels of expres-
sion are apparent, all SCV antigens recognized at 28 days p.i.
are also present in the LCV. A small subset of these common
antigens is also recognized by vaccinated animals that were
challenged with live organisms. The less complex humoral re-
sponse elicited by vaccination and subsequent infection is not
unexpected and has been reported elsewhere for C. burnetii
(40). At least two antigens with approximate molecular masses
of 42 and 84 kDa appear unique to the LCV. Like P1, these
antigens may be surface exposed and involved in nutrient up-
take by the LCV. Moreover, antigenic variation in vivo be-
tween the SCV and the LCV may play a role in the immune
evasion and persistence of C. burnetii that lead to chronic
infections (39).
An infected guinea pig first generates antibodies to 12.5- and
15-kDa antigens with strong recognition of these proteins
throughout the course of infection. Similar reactivities are ob-
served with sera derived from vaccinated animals. Based on
immunoblot signal intensities, these antigens appear more
abundant in the SCV than in the LCV. Diagnosis of Q fever is
usually by serological methods with the reference technique
being microimmunofluorescence (19). This test employs inac-
tivated whole-cell C. burnetii as antigen. A serodiagnostic test
based on recombinant antigen would eliminate the need for
cultivation and purification of C. burnetii and would likely be
more specific. As the 12.5- and 15-kDa antigens are the pre-
dominant antigens recognized during the early stages of infec-
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tion, they may have utility as serological diagnostic target an-
tigens in the form of recombinant protein. At 28 days p.i., LPS
comprises a portion of the 12.5-kDa-antigen reactivity. C. bur-
netii LPS is strongly immunogenic and also comprises the or-
ganism’s phase I antigen (41). Recognition of LPS only late in
infection is in keeping with the serological phenomenon of
phase variation whereby only late antiserum (20 days p.i.) of
an infected animal binds to phase I antigen (i.e., LPS) (23).
Consistent with a previous report (20), there appears to be
more LPS associated with the SCV than with the LCV.
To develop a more complete understanding of the human
humoral response to C. burnetii, we identified immunogenic
proteins recognized in the context of human acute Q fever.
Similar to the reactivity observed with infected guinea pig sera,
human convalescent-phase sera recognize a greater number of
LCV than SCV proteins. While a number of SCV- and LCV-
specific proteins are recognized by convalescent-phase sera, in
most cases these are weakly immunogenic. However, one hu-
man serum strongly recognized two LCV-specific proteins: Bcp
and repressor protein C2. C2 is an S24 peptidase family au-
topeptidase which is commonly involved in activation of RecA
(18). As discussed earlier, Bcp may protect C. burnetii against
oxidative stress. Selective recognition by the human immune
system of both proteins only in the LCV is consistent with an
elevated stress response by this developmental form. The re-
maining identified antigens are present in both the SCV and
the LCV with GroEL, RplJ, and FabF recognized by both
human sera in both cell forms. GroEL and the ribosomal
protein L9 were recently identified as immunogens by screen-
ing a C. burnetii expression library with serum from Coxiella-
infected mice (40). FabF, an enzyme involved in fatty acid
biosynthesis; Icd, a Krebs’ cycle enzyme; and AtpA, a subunit
of ATP synthase, are considered housekeeping enzymes. How-
ever, antigenic C. burnetii housekeeping proteins have been
reported elsewhere (40), indicating that general metabolic en-
zymes of the organism are exposed to the host immune system.
AdaA, EF-Tu, AtpA, and Icd were recognized in both SCV
and LCV lysates by a single convalescent-phase serum. AdaA
was recently identified as an immunodominant outer mem-
brane protein synthesized only by isolates acquired from pa-
tients with acute disease (42), and mice generate an antibody
response to EF-Tu when vaccinated with formalin-fixed C.
burnetii (26). One human serum recognized Tig, an abundant
ribosome-associated chaperone (6), in both SCV and LCV
lysates while the other human serum recognized Tig only in
LCV lysates.
In summary, this study provides an extensive proteome anal-
ysis of C. burnetii developmental forms. Identification of cell-
form-specific and common antigens provides new information
for development of rationally designed subunit vaccines and
new diagnostic tests. This is particularly relevant with respect
to surface antigens of the SCV, the environmentally stable cell
form.
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